Esperion Therapeutics, Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Esperion Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Esperion Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Esperion Therapeutics, Inc. annual Depreciation for 2023 was $164K, a 67.2% decline from 2022.
  • Esperion Therapeutics, Inc. annual Depreciation for 2022 was $500K, a 18.3% decline from 2021.
  • Esperion Therapeutics, Inc. annual Depreciation for 2021 was $612K, a 11.9% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $164K -$336K -67.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $500K -$112K -18.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $612K +$65K +11.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-21
2020 $547K +$228K +71.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-22
2019 $319K +$54K +20.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $265K +$7K +2.71% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $258K +$6K +2.38% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $252K +$16K +6.78% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $236K +$76K +47.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 $160K +$89K +125% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $71K -$68K -48.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $139K -$39.5K -22.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-10
2011 $178K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.